By Integrated Home Care Services
Published November 11, 2026 · Last updated November 11, 2026 · 4-minute read
Key Takeaways
- Broad, one-size-fits-all prior authorization (PA) creates friction for members and providers, while removing PA altogether creates exposure to fraud, waste, and abuse.
- CMS-0057-F holds a $30 DME order to the same standard as a high-cost surgery, and the rule was not designed around the operational realities of care at home.
- The answer isn’t more PA or less PA. It’s precise PA: applied where the data shows risk and lightened where providers have earned trust.
Prior authorization (PA) for home-based care has never followed a single playbook. Requirements vary by state, by plan, and by line of business. Some health plans apply PA broadly across durable medical equipment (DME), home health, and home infusion while others have dropped it in these categories to speed up the start of care. Neither extreme fully accounts for the complexity of home-based care.
Broad, one-size-fits-all PA creates friction for members and providers. In a KFF survey of insured adults, people whose insurance problems involved prior authorization were about three times as likely to report significant delays in care (32% vs. 11%), and about twice as likely to say their health declined as a result (26% vs. 11%) compared to people whose problems did not involve PA.
Removing PA altogether creates a different problem: exposure to fraud, waste, and abuse (FWA). DME remains a persistent target. In an August 2026 white paper, the HHS Office of Inspector General (OIG) described Operation Gold Rush, a transnational scheme accused of billing Medicare more than $10 billion for DME and supplies and collecting $941 million from Medicare and secondary payers before it was shut down. In September 2026, CMS barred 11 DME suppliers from receiving Medicare Advantage and Part D payments after identifying more than $3.4 billion in suspected fraudulent billing across 2025 and 2026.
Because home-based care is high-frequency, recurring, and low-dollar per unit, a duplicate order, an extra nursing visit, or the wrong site of care adds up quickly across a membership. The same dynamic applies to private duty nursing (PDN) and long-term services and supports (LTSS), with the added layer of state waiver rules.
The answer isn’t more PA or less PA. It’s precise PA: applied where the data shows risk, lightened where providers have earned trust, and run fast enough that it never becomes the reason care starts late. That is how Integrated Home Care Services (Integrated) approaches prior authorization, and it’s exactly the kind of discipline CMS-0057-F is designed to support.
Part one of this series covered what CMS-0057-F asks of health plans. This post covers why home-based care is different and why precise PA is the right response.
Why Home-Based Care Is Different
CMS-0057-F applies the same clock and the same denial-reason requirements to every medical item and service that requires PA, regardless of cost or frequency. A single high-cost surgery is held to the same standard as a $30 DME order, a PDN visit, or a monthly oxygen rental.
DME, home health, and home infusion generate a large volume of low-dollar, recurring requests, so a PA process that works for occasional procedures can buckle under home care volume, putting both decision timeframes and publicly reported metrics at risk. The rule was not designed around the operational realities of care at home.
PDN and LTSS/personal care add another layer. These services often sit inside the same Medicaid managed care programs, but coverage varies by state, largely through two Medicaid authorities: 1915(c) waivers, which let states offer home and community-based services (HCBS) as an alternative to institutional care, and 1915(i) state plan benefits, which let states offer HCBS to specific target populations. Applying the wrong state’s rules means rework, delays, and compliance risk under the new clock.
Precise Prior Authorization, Not Blanket Prior Authorization
Under time pressure, some plans may be tempted to remove PA from home-based categories entirely. That trades one problem for another. Without any review, plans lose visibility into duplicate DME orders, unnecessary equipment upgrades, home health visits beyond what the plan of care supports, and infusion services delivered in a costlier setting than needed.
The industry is moving toward a middle path. Under voluntary commitments announced in June 2025, participating health plans pledged to reduce the scope of services subject to PA and to answer, by 2027, at least 80% of electronic PA approvals in real time when requests are submitted with complete documentation. In a June 2026 progress update, AHIP and the Blue Cross Blue Shield Association reported that participating plans expect roughly 11% fewer prior authorizations in 2026, while keeping review focused on high-risk, high-cost care decisions.
CMS applies similar logic in traditional Medicare (in select states): under the Home Health Review Choice Demonstration, agencies that reach a 90% affirmation or claim approval rate can move to lighter review options, including spot checks of 5% of their claims every six months.
Integrated applies PA the same way. We use it selectively, in the categories and with the providers where utilization data signals risk, and keep it out of the way everywhere else. That approach does two things at once:
- It spotlights high performers. Providers with a strong record of clinically appropriate, well-documented requests move faster with less friction. That rewards quality and keeps the network’s best partners engaged.
- It applies a fine-tooth comb where it matters. High-risk codes and outlier patterns, such as unusual order volumes, new suppliers with no billing history, repeated upgrades, or orders that don’t match a member’s diagnoses, get closer clinical review before dollars go out the door.
The result is PA that protects members and plan dollars without becoming the reason care starts late.
Want to see how Integrated delivers CMS-0057-F compliance and utilization management savings without trading one for the other? Let’s talk.
Regulatory References
- Same decision timeframes and denial-reason requirements for every item and service requiring PA: 42 C.F.R. §§ 422.122(a), 422.568(b)(1)(ii), 422.572(a)(1); parallel Medicaid managed care provision at 42 C.F.R. § 438.210.
- Public reporting of PA metrics: 42 C.F.R. § 422.122(c).
